How do you turn hope into action? A doctor and a public health expert answer | David Fajgenbaum and Celina de Sola

Summary

Podcast Summary: TED Talks Daily

Episode: How do you turn hope into action? A doctor and a public health expert answer | David Fajgenbaum and Celina de Sola

Date: September 26, 2025

---

Episode Overview

This episode features an unscripted, in-depth conversation between immunology researcher Dr. David Fajgenbaum (founder of Every Cure) and public health expert Celina de Sola (co-founder of Glasswing International). Host Elise Hu introduces the discussion, which centers on how to navigate hope and despair while driving real-world solutions in the fields of medicine and trauma-informed public health. The guests share personal stories, explore systemic challenges, and discuss actionable insights to effect transformative change in their respective sectors.

---

Key Discussion Points & Insights

1. Holding Hope and Despair Simultaneously

• Balancing Emotions for Change:
  • Celina de Sola emphasizes the importance of accepting both hope and despair as motivators:

    “I feel like you can hold hope and despair at the same time…how do we hold those simultaneously in a way that enables us to keep working and keep learning and…collaborating?” (02:28)

  • This theme recurs throughout as both guests reflect on the duality of working with suffering populations while aiming for systemic change.

2. Personal Journeys Fueling Innovation

• David Fajgenbaum’s Story:
  • Became critically ill with Castleman disease at a young age—an experience that catalyzed his focus on drug repurposing:

    “I went from being this healthy third year med student…to becoming critically ill…nearly died five times…before eventually discovering a drug that wasn’t made for my disease, that could save my life.” (04:50)

  • Fajgenbaum now leads Every Cure, an initiative using AI to scan global medical data to find new uses for existing drugs.
• Celina de Sola’s Approach:
  • Founded Glasswing International in El Salvador to create trauma-informed care systems, especially in contexts of violence:

    “We’re trying to create systems that are more trauma informed…so kids and families can navigate adversity…and thrive.” (03:26)

  • Focus on working in public schools and with law enforcement for wider impact.

3. Systemic Barriers and Solutions

• Repurposing Existing Resources:
  • Both advocate for maximizing what’s already in place—whether medicines or human resources:

    “We have the solutions there, right?...How do we really capitalize on these resources that are sometimes latent…” – Celina de Sola (11:40)

  • Fajgenbaum illustrates this with patient stories where existing drugs saved lives with previously unrecognized applications.
• Building Trauma-Informed Systems:
  • De Sola recounts a police officer’s transformation through trauma training, which later scaled to national police programs:

    “We've been able to work with national police in three countries and they're integrating mental health training as part of their cadet training.” (08:01)

4. Managing Setbacks and Sustaining Motivation

• Embracing Successes and Losses:
  • When asked how he copes with patients for whom no cure is found, Fajgenbaum stresses leveraging both failed and successful cases as motivation:

    “It’s also really motivating. It just, you know, pushes us to work harder and harder.” (12:07)

  • De Sola echoes this, highlighting the need to draw inspiration from those helped, while also acknowledging pain and exhaustion as part of the process:

    “I feel like you can hold hope and despair at the same time…how do we hold those simultaneously in a way that enables us to keep working and keep learning and…collaborating…” (14:33)

5. Scaling Impact without Losing Depth

• From Local to Systematic Change:
  • Both guests started with focused, local interventions that evolved into national or global initiatives.
  • De Sola uses a “systems R&D” analogy:

    “If we’re working deeply and long term in communities…with mental health we knew there was an opportunity to do non clinical work…now there’s a huge demand for it.” (15:27)

  • Fajgenbaum details rapid scaling enabled by AI:

    “When we built our first AI platform…to compute 75 million scores…it took 100 days. Now…about 17 hours to compute the same 75 million scores.” (17:32)

6. Advice for Systemic Changemakers

• David Fajgenbaum’s Framework:
  • Understand existing systemic gaps before acting.
  • Iterate rapidly: “Get into the space, start helping people…then start asking about the system. But don’t stop asking questions…” (21:18)
  • Build a diverse team, especially for areas outside one's expertise:

    “I really don’t have strengths in systems and policy and so I’ve got amazing colleagues…” (21:18)

• Celina de Sola’s Emphasis:
  • Importance of continuous local engagement, alignment with diverse stakeholders, and maintaining both breadth and depth.

7. Resilience, Vision, and Leadership

• Staying the Course Against Big Challenges:
  • Fajgenbaum’s three keys:
    1. Vision—being able to literally visualize the outcome.
    2. Team—having people by one's side.
    3. Small Steps—breaking down challenges.

    “If someone…said, we want you to create what you have now, you’d have been like, no way…But I think taking those little tiny bite-sized pieces…helps me.” (24:35)

  • De Sola cites Viktor Frankl’s “Man’s Search for Meaning” as a touchstone for hope through visualization. (25:59)

8. Hope That Drives Action

• The Power and Pitfalls of Hope:
  • Fajgenbaum distinguishes between passive and active hope:

    “The type of hope that I love so much is the hope that drives action…when there’s this hope and action circuit, you can get even more hopeful and then do even more action…” (26:43)

  • Both reflect on how hope, when connected to action, is cyclical and sustaining.

9. Leadership, Team Building, and Humility

• Styles and Strategies:
  • De Sola advocates collaborative leadership and knowing when to step back:

    “So much of leadership is…knowing when to get out of the way. And asking for help.” (27:58)

  • Fajgenbaum prioritizes assembling mission-driven teams and overcommunicating vision:

    “Being able to set that vision…constantly remind everyone of what that vision is.” (28:58)

  • Emphasis on humility and curiosity when working with system partners:

    “Maintain the humility and curiosity about…what they need, what their priorities are…” (30:41)

  • Both agree diversity, perseverance, and genuine curiosity are essential for sustained impact.

---

Memorable Quotes and Moments

• “You can hold hope and despair at the same time.” – Celina de Sola (02:28, 14:33)
• “All I’ve been able to think about is how many more drugs are out there that are made for one disease that could actually save way more lives.” – David Fajgenbaum (04:50)
• “It’s all about impact, that’s why we do what we do.” – David Fajgenbaum (09:37)
• “Joseph and Tara, a year and a half ago, were planning Joseph’s funeral. Now they’re planning their wedding together.” – David Fajgenbaum (11:18)
• “Hope that drives action…when there’s this hope and action circuit, I find that you can get even more hopeful and then do even more action and then be more hopeful and drive even more change.” – David Fajgenbaum (26:43)
• “So much of leadership is about doing things together and knowing when to get out of the way. Right. And I think. And asking for help.” – Celina de Sola (27:58)
• “If it was easy to solve, someone else would have done it and we wouldn’t be working so hard.” – David Fajgenbaum (31:35)

---

Notable Timestamps

• 02:28: Celina de Sola on hope and despair
• 03:11: Fajgenbaum on AI-driven drug repurposing
• 04:50: Fajgenbaum’s personal medical odyssey
• 08:01: De Sola’s story of a police officer’s transformation
• 09:37: Fajgenbaum on impact and a success story (Joseph)
• 11:18: The story arc from patient despair to hope
• 12:07: Discussing setbacks and motivation
• 15:27: Scaling trauma-informed work in Glasswing
• 17:32: How AI supercharged drug repurposing scale
• 21:18: Fajgenbaum’s systemic change advice
• 24:35: Keys for facing overwhelming challenges
• 26:43: Hope that drives versus stifles action
• 27:58: Approaches to leadership and team-building
• 30:41: The necessity of humility and curiosity in leadership

---

Tone and Feel

The conversation is authentic, vulnerable, and deeply hopeful—marked by stories of personal and systemic struggle, coupled with pragmatic optimism. Both guests balance intellectual rigor with heartfelt compassion, emphasizing real-world application, resilience in the face of setbacks, and the persistent quest to turn hope into transformative action.

Transcript

[Selena de Sola]

Only Boost Mobile Boost Mobile will give you a free year of service. Free year when you buy a new 5G phone. New 5G phone?

[Elise Hu]

Enough.

[David Fagenbaum]

But I'm your hype man. When you purchase an eligible device, you get $25 off every month for 12 months with credits totaling one year of free service. Taxes extra for the device and service plan online only.

[Selena de Sola]

This episode is brought to you by Capital One. Capital One's tech team isn't just talking about multi agentic AI. They already deployed one. It's called Chat Concierge and it's simplifying car shopping using self reflection and layered reasoning with live API checks. It doesn't just help buyers find a car they love, it helps schedule a test drive, get pre approved for financing and estimate trade in value. Advanced, intuitive and deployed. That's how they stack. That's technology at Capital One.

[Elise Hu]

This episode is brought to you by On Location Events. The FIFA World Cup 26 is coming to North America next summer. It'll be the ultimate celebration of sports and culture. Get closer to the beautiful game with a hospitality package closer to the action in the best seats and suites, closer to match day elevated world class food and entertainment closer to the experience of a lifetime. Book a hospitality [e-mail] Hospitality. You're listening to Ted Talks Daily where we bring you new ideas to spark your curiosity every day. I'm your host Elise Hu. In the face of immense challenges, how do you hold on to hope while still being realistic about the work that needs to be done? In this new episode of TED Intersections, our original series that features unscripted conversations between speakers and experts taking on subjects at the intersection of their expertise. Public health expert Selena de Sola sits down with immunology researcher David Fagenbaum to explore how they continue to move forward with the exploration and implementation of bold life saving ideas even in the face of setbacks, they discuss why it's so important to keep an open mind and share how learning to hold space for both hope and grief has made them more successful in their work.

[Selena de Sola]

I feel like you can hold hope and despair at the same time, right? Like it's okay to hold those things because if, if you're trying to be hopeful, it's we can't really always let go of the the sadness and the despair and the frustration. So it's like how do we hold those simultaneously in a way that enables us to keep working and keep learning and you know, and collaborating? I'd love to hear about your work. What are you working on? What are you doing?

[David Fagenbaum]

Sure. So I'm on a mission to save and improve lives with the drugs that we already have. We use an AI platform to scan across the world's knowledge of every drug and every disease to find out new uses for the medicines that we already have.

[Selena de Sola]

That's amazing.

[David Fagenbaum]

Then tell me about yourself.

[Selena de Sola]

So we're actually, we were founded in El Salvador. We're an organization that was founded in El Salvador and we're trying to create systems that are more trauma informed, to make sure, especially in context of violence, but to make sure so kids and families can navigate the adversity they face and thrive. Right. Instead of just struggling with the impacts of stress and trauma on their lives. And we work in public schools too, to make sure that those schools are safe spaces where they can learn and receive the support they need.

[David Fagenbaum]

What is it about the system that made you really want to tackle this problem?

[Selena de Sola]

I think that we realized that we didn't really see that most people, just society in general, but also teachers, nurses, doctors, the systems we were working with didn't have an understanding or the necessary understanding of the impacts of stress and trauma. So we wanted to figure out how we could provide that knowledge, those skills, so everyone that children and young people and families would interact with in these systems, education, health, law enforcement, would be able to do that, to provide, you know, to provide a service that is more trauma informed and understands why people behave the way they do and how we can change that, you know, how we can change the way we interact.

[David Fagenbaum]

And I was reading about your work. You've had such an incredible impact. It's just. It's just amazing.

[Selena de Sola]

Likewise, I'd love to hear about you. I read about your story and I'd love for you to tell me a little bit more about it in person.

[David Fagenbaum]

Sure, yeah. So I went from being this healthy third year med student at Penn, where I know we both were students, to becoming critically ill. My organs started to shut down. My liver, my kidneys, my bone marrow, my heart, my lungs. And I went from being this totally healthy med student to being critically ill. So 15 years ago was when I went into the hospital and ICU and nearly died five times over the course of a three year period from this horrible disease called Kasselman disease before eventually getting a diagnos, beginning to receive chemotherapy, and then discovering a drug that wasn't made for my disease, that could save my life, a drug that was made for organ transplant rejection I thought could maybe treat my disease. And I started testing it on myself. And it's been 11 and a half years that I've been in remission on this medicine. Thank you. I mean, the moment that this drug started saving my life, all I've been able to think about is how many more drugs are out there that are made for one disease that could actually save way more lives. And that's just become my complete obsession. And now we've got this nonprofit working on it.

[Selena de Sola]

That's unbelievable. But how did you think of seeing if one medicine could work for something else? Obviously you have a medical background, but how did that actually happen? Like what, you know, what brought you to actually say, I'm going to. I know there's something out there. Right. I know there's something.

[David Fagenbaum]

Well, it was a couple things. So. One was that I'd been getting seven different chemotherapy drugs with each of my relapses. Every time I was in icu, they'd give me seven chemotherapies, but they weren't made for my disease. And I kept thinking to myself, everyone's telling me there's no drugs for Kasselman's, but you keep giving me chemotherapy, and they don't work long term, but they're saving my life. Maybe there's another drug made for another disease. It was just sort of that. That simple of a concept. It's like, these things work. Maybe there's something else could work. And then the other was just the realization that I had no other option. I didn't have a billion dollars in 15 years to create a brand new drug. If I wanted to survive, I would have to find something that existed. So it was sort of the constraints of the system. And. And then what's been so crazy is just how many drugs there are out there that can help more people that. That we've been neglecting for so long.

[Selena de Sola]

Yeah. Unbelievable. And so much funding's gone into developing those drugs, too. So it's like you already have all this R and D. Yes. What. What can you do to.

[David Fagenbaum]

To make the most of that? Exactly. And so let's think about how this relates back to the work that you're doing. I mean, we've got systems that are broken that you guys are working to address. How do you try to leverage maybe what's already in place? I don't know. Or maybe you just try to start from scratch. How do you think about.

[Selena de Sola]

You know, I think for us, we were working. You know, I'm from El Salvador. We were working in some of the countries that had the highest rates of violence about 20 years ago when we started. And before that, I Did humanitarian aid. So I worked mainly in countries affected by conflict and natural disasters and we were just seeing that we weren't equipped, our systems aren't equipped to deal with so many of these things and, and, and mental health and well being, which I think we understand a lot better now after the pandemic, are so foundational for other outcomes. Right. You can't access learning your physiological, traditional, what we consider traditional physiological health weakens or worsens if you're not well emotionally. So we were seeing that and we were also under. We also understood that the best way to address, we knew from science that the best way to under to address the impacts of stress and trauma in children is a caring adult in their life.

[David Fagenbaum]

And can you maybe share about an individual that has really been touched by your work? I'd love to hear a personal story.

[Selena de Sola]

Oh my gosh, there's so many. But one of them comes to mind. I think it's, you know, when you work with young people, most organizations that work with young people don't necessarily work with law enforcement. And when we were looking at what the ecosystem was that we wanted to convert into something more trauma informed, we wanted to include law enforcement because we knew young and young people interact with police in sometimes great ways, sometimes not great ways. Right. In different ways. So one police officer that we were working with, she was explaining how difficult it is to take calls. She was working in a really tough municipality, high rates of homicide and crime, and how it changes you to be exposed constantly to human suffering, which I'm sure it does in medicine too. Right. You're just exposed to human suffering. How do you get through that? How it changes you? So we started working after training a lot of officers, you know, and she became a trainer and an interventionist. She was explaining that now not only was she better able to manage her own, to self regulate, to feel better and be well, but she was able to provide that for her peers. Right. So it changed the way they interacted with communities. And interestingly, right. When you talk to young people, she was afraid. For example, I don't know if I leave today if I'm going to come back alive. And a lot of young people would tell us the same thing in their community. So it was, you know, identifying these opportunities. And now a few years later, we've been able to work with national police in three countries and they're integrating mental health training as part of their cadet training. So we're really excited. I'd love to hear. Tell me about you. I know you've Been working so much on systems, and I'm really excited to hear about it.

[David Fagenbaum]

Well, thank you. I mean, just as you said before, this is. It's all about impact. That's why we do what we do. And for you, your impact is so broad reaching and also so deep within these individuals, within communities. And for us, similarly, we have a very bold and broad mission, and that's to save and improve lives with the drugs we already have by repurposing medicines. We're called Every Cure, which is a big, broad remit. But I'll share with you about one patient in particular named Joseph. And actually he was at the TED Talk that I gave just a few months ago and was able to be there in the audience, which was so special because I told his story during the talk. And his story is that he was critically ill with a horrible, rare cancer called Poem Syndrome.

[Selena de Sola]

And.

[David Fagenbaum]

And his doctors had tried everything the doctors knew to try for this rare cancer. And his girlfriend, Tara, reached out to my team on a Friday. Joseph was getting ready, transferred to hospice care on that Monday because nothing was working. And I was able to get in touch with his doctor on that Saturday and recommend three drugs that were made for multiple myeloma, which is a cancer that's similar to Poem syndrome, but those drugs are not used for poems. And the doctor and I had a long discussion, and there were a lot of debates about whether, you know, whether he could tolerate these medicines and whether we should sort of give this last Hail Mary effort. And the doctor decided to try the medicines. And amazingly, Joseph responded incredibly well. About by that Thursday, he was out of the icu. And now it's been over a year. It's almost a year and a half now. He's been in remission. These drugs were always there. They were just made for a different disease. A disease actually is very similar to the disease that. That he has. And it's just been so special to see patients like Joseph get their lives back. Joseph and Tara, a year and a half ago, were planning Joseph's funeral. Now they're planning their wedding together. And, you know, this idea that the medicine was there, but we humans hadn't done the work to match it together. It's just what drives us. We've got so many solutions out there, and we got to help patients with them.

[Selena de Sola]

It's unbelievable. It is. We have the solutions there, right? You. You have the medicines and the compounds there, and we have the human resources that are already there. It's like, how do we really capitalize on these resources that are sometimes latent with regards to other things they can do. But what do you do to stay optimistic? Like, what do you do with the setbacks when you have a patient and you just can't find that cure? And how do you manage that?

[David Fagenbaum]

Yeah, I mean, there are many cases where we aren't able to find a repurposed drug for a patient, and they do pass away from their disease. And it's just so heartbreaking when you have a personal mission like the two of us have, where that's all we can think about, and it's what drives us. And. And certainly when I've gone through similar experiences and to be on the other side, it's heartbreaking when you're not able to. To find the solution. It's also really motivating. It just, you know, pushes us to work harder and harder. And then there's patients like Joseph and others that we've been able to help and save that motivates us even further. It's the setbacks, the cases where we're not able to help patients, and then also the patients where we are able to help patients. It's really created a circuit. And anytime I'm struggling to, you know, with the challenges of this nonprofit, of every cure, and the work that we do in research, I just think about what these patients are going through, which just, you know, what we're doing pales in comparison to the suffering that they're going through. And just. We're just trying to stay as motivated as we can to find solutions. What about you? How do you get through these challenges and these setbacks?

[Selena de Sola]

Yeah, I mean, it's hard, right? I mean, I just got a text yesterday from someone, a nurse at a clinic that we've been working in, the schools we work in, public schools in different parts of the countries we work in. And she called me, and she was telling me about a girl who had survived, you know, violence, and she was pregnant four months. It's just this horrible story. In a really tough situation, she was asking for intervention. There's, you know, this. The worry around teen suicide and just support. Right. And I. And. And you hear these horrible stories, and I agree with you. It's like, how do we focus on the successes, right? And. And then also in those successes, how do we try to support other people around us who are working on these same issues, you know, whether they're in government or nonprofit? And I think, you know, for me, there are days, right, where you just exhausted, and you're like, oh, you feel like you're Kind of running in place and everything's so urgent. I mean, you're saving lives, right? We're trying to keep people also like trying to save lives, trying to prevent the perpetuation of violence. And I think I also draw inspiration from the successes and from the people we work with, that determination. And then one thing I've come to terms with in the last few years is that I feel like you can hold hope and despair at the same time. Right? Like it's okay to hold those things because if you're trying to be hopeful, you can't really always let go of the sadness and the despair and the frustration. So it's like, how do we hold those simultaneously in a way that enables us to keep working and keep learning and you know, and collaborating and almost.

[David Fagenbaum]

What you're saying is almost like sitting with the pain sometimes. And I think that it's a, it's a sitting with the pain, sitting in our cases with loved ones of patients who didn't make it, patients who are suffering. It's, you know, understanding like what the stakes are and then to your point, celebrating and really leaning on the mentality and the positive outlook of the cases where you're able to help. And it sounds like you're going through the same sort of thing. How do you think about scale? So obviously you started hyper local and you've really grown in scale. Have you thought about scaling the impact of your work?

[Selena de Sola]

Yeah, I mean, we started volunteering in schools, right? Like how can we be a caring adult for a kid? Almost 20 years ago when we started Glasswing and I think we just over time started hearing from the students and from the teachers, aside from the work we were doing to meet basic needs, so to speak, infrastructure, provide after school programs, learning opportunities. We just started seeing that there was this underlying issue and we were seeing kind of the negative impacts of the exposure to stress and trauma. So I think for us we've always worked within systems with this idea. I guess the analogy for your sector would be it's almost like R and D for systems, right? So we're like, how can we learn from students, from parents, from teachers, if we're working deeply in long term in communities? And that's what we've been doing. So with mental health, we knew that there was an opportunity to do non clinical work by doing this psychoeducation trauma education and you know, fast forward, we were able to get the funding through Audacious, we were able to get the resources and now it's really exciting. Is that because there's such a demand. And the stigma has been, there's been such stigma around this, which has improved during the pandemic, but now there's a huge demand for it. So the exciting thing is these systems, they want this to be a part of what they do. Not just from a human resource standpoint, retention, performance, everything, quality of care, but also it's become like a priority. So now we're, you know, the curricula, mental health training is being integrated into teachers, colleges that we're working with, or medical schools, nursing, child protection judges. So it's almost demand driven, which is really exciting. And then also making sure we're constantly learning and adapting and, and responding and listening to those we work with to make sure that we're really achieving this whole vision of ecosystems and systems change. But in our case, there's no doubt we have to work with public sector. Right. To reach as many people as we can. We also see them as a huge frontline, workers in particular as a huge resource.

[David Fagenbaum]

Wow. Well, I see parallels in our work in that, you know, it started very, I guess I'd say hyper local with me in the sense that I was very sick and found a drug that I repurposed for myself. And then, and immediately sort of like you started thinking, okay, if this drug worked for me, are there other drugs that could work for other patients? And first it was just Kasselman's patients. And then we started looking at diseases related to Kasman's other rare diseases. We've now repurposed 14 drugs for diseases they weren't intended for. And now thousands of patients are alive because of these drugs that weren't made for their disease. But about three years ago, we decided to really scale things. And that was with the creation of this nonprofit, EveryCure. And it really coincided with the emergence of artificial intelligence. So I run a lab at the University of Pennsylvania and our lab, I'm very proud of our team. We can study a couple drugs for a couple diseases a year and make a lot of progress. And we are really proud of that. But then when you think about what artificial intelligence can do to scan across the world's knowledge of every drug and every disease quickly, almost instantly, right. To come up with predictions on how likely drugs are to work in new diseases, it's. It's really mind boggling and just like to sort of put some numbers around it. When we built our first AI platform about two and a half years ago and ran it for the first time, it took us 100 days to compute 75 million scores because there's 4,000 drugs and there's 18,000 diseases. So if you tried every drug for every disease, it would be 75 million possibilities. Took 100 days. Now it takes about 17 hours to compute the same 75 million scores. The scores are really accurate. They're telling us that drugs like lidocaine can help potential patients with breast cancer. Things that, you know, our brains would have never just, you know, gone to immediately. But what's so interesting also is that a lot of these insights are based on research that we humans have already done. You know, we've studied this drug in the lab for this disease and maybe showed promise. But then we moved on to that drug for that disease, because this wasn't a profitable opportunity, or maybe this was a better opportunity, opportunity for someone's career. And so there's all these breadcrumbs that have sort of been spread all over the medical research system. And artificial intelligence is so good at picking up those breadcrumbs, making the connections. And then it's really up to us. And like you, we won an audacious project award this past year, and now it's up to us to leverage the power of artificial intelligence to look across 75 million possibilities. But then for us humans to say, this drug for this disease really needs to be studied in the lab. This one needs to be studied in clinical trials, and this one, we have to get to patients. One of those diseases that I talked about in my TED talk that I shared in spring is a drug called leucovorin. It was developed for patients on a form of chemotherapy decades ago and then used for another form along with another form of chemotherapy decades ago. Turns out that a fraction of children have antibodies to prevent a vitamin from getting in their brain. But if you give them this old drug that was developed to be given to patients on chemotherapy, it can help to get that vitamin folate into their brain. And for a fraction of these kids, that can help them to speak, improve their verbal communication skills. And, you know, this sort of thing where it's like, us humans, we made the connection. Brilliant work was done, but the last mile wasn't taken. And that's because it's a cheap old drug. And it's not that anyone wants to suppress the information. It's just that no one's incentivized to get the word out. There's no drug company behind this. And so these are the kinds of, like, sort of systems problems that exist that you see and I see every day where it's like one little tweak here or there can really unlock a lot of value and potential.

[Selena de Sola]

So how did you transition right from what you were doing, the deep work, into the systems work? And what, what would you tell other people? Like, what would you advise, you know, what would you advise other people who are trying to push forward their vision?

[David Fagenbaum]

I think if you observe a major problem like you did and like I did, I think it's really important when you start to solve it, to ask questions around what's already being done within the system. Let's not try to reinvent the wheel like you mentioned, you know, let's, let's see what already exists. And so I started asking more and more questions. Physicians, researchers, pharmaceutical companies, government agencies, you know, there must be someone working in our system to try to find new uses for old medicines. Like, there's gotta be some entity that's responsible for making sure the drugs we have work for all the patients, they can benefit. And the more I look, the more I learned that there wasn't this system. And so then I started trying to understand, okay, well, what are, what does exist and what can we, you know, what gaps can we fill in? So I think the advice is really get into the space, get going. I think a lot of times people want to sort of like do a lot of, you know, fact finding, a lot of learning. I wonder what's going on here. It's get into the space, start helping people, start doing the work, start trying to fix the problem, then start asking about the system. But don't stop asking questions until you figure out as much as you can about the system. And then I think maybe I'd say the third piece of advice would be to make sure that you've got an awesome team. I mean, so for me, I know a lot about drug repurposing and a lot about immunology, and I can match drugs and diseases, but I really don't have strengths in systems and policy. And so I've got amazing colleagues who I can work with that can help us to make these sorts of changes.

[Selena de Sola]

Yeah, I totally agree with you. I think the team is key because we all have different skills, right? Like the linear thinking, the more creative thinking. And I think you're right. It's like what does exist for us, that was always really important. It was important for us to be a local organization, right, like, like, you know, founded and based in Latin America and really making sure that we were listening. I think what you said about asking questions and I think asking beforehand, but also continuing to ask, right, like what Else is there continuing to understand the systems we're working in and, and their priorities? Because I feel like if we can, even if we don't necessarily align in so many other, with other things like politically or, you know, whatever it is, I think we can align what we can align or when we find those things that we can align on, you can really drive change together. And for us working with public systems, there was no question. Right. We know we can never reach everybody. And even though governments change, that's the other thing that for us was important. When working with systems change, it's not just working with government officials that are appointed and in that administration, it's working at the operational level with people who are working every day, whether teachers, administrators, mid level professionals, regional coordinators. So really thinking about the people within government systems that, you know, they outlive government changes because they're working there. And it's also they have this vocational drive, like they have this vocation to be there, this desire to be in these systems. So I think for us it was important to make sure that we continue to engage people who are part of these systems at all levels. Not just going from the community to the ministers, but everywhere in between. And thinking big, right? Thinking big, but also maintaining that depth, that depth of work with individuals, with young people, with communities. Because you can do both. You can do both. And I think if you don't really understand deeply what challenges are, it's really hard to work on systems change and scale.

[David Fagenbaum]

That's great. Yeah. I think about facing challenges. I think that you need at least three things to be able to overcome a big challenge. I think what we're doing could certainly describe as big challenges. One of them is I think you have to have a vision for what you're working towards. Because when you're going through tough times, like if you don't know what you're fighting for, can't literally visualize it. I just don't think, at least for me, I can't, I can't, you know, keep the fight going. And I remember this back from when I was in the intensive care unit. Literally, as I said, Today marks 15 years from when I was first hospitalized. And I just remember that I thought so much about one day I'm going to be able to search for treatments in memory of my mom. One day I'm going to be able to, to maybe get married to this amazing person that I was with Caitlin. But that vision, I think is so important. The second is the people by your side, the team that you've got, you've got to have an amazing team supporting you. And for me, I was lucky when I was so sick to have such great support around me. And the third, I think it's really this one step at a time, that grind that you were kind of describing, like meeting with these people and those people and doing this and that. I think you have to take it one, one step at a time because it's just too overwhelming. If someone had gone to you on the first day you were volunteering at the first school and said, we want you to create what you have now, you'd have been like, no way. Or at least I would have said no way. Like, I can't do that. I could, I can do this one thing, but I can't do that other thing. But I think taking those little tiny bite sized pieces, at least for me, I think that that helps, helps me to do this sort of stuff.

[Selena de Sola]

Yeah. Because it's always overwhelming. Right, right. So it's like those bite sized, it's helpful, I think. And you know when you were talking about visualizing, one of my favorite books is Man's Search for Meaning by Victor Frankl. And I remember in that book he, he, he does a lot of visualizing. Right. And a lot of thinking about it. And I think hope, get having hope sometimes or off often or perhaps always requires being able to envision.

[David Fagenbaum]

Yes.

[Selena de Sola]

You know, you sitting in this hospital room and they told you they can't save you. I can't imagine what that must have been like. That must have been so heartbreaking. So heartbreaking. So young and why. Right. All these things. So I think that's a really good point and something that I think we always have to do in this sector to not fry, burn out.

[David Fagenbaum]

Yeah. I'm so glad you mentioned hope. Hope is, as you know, so powerful. It's like you have to have hope to overcome any challenge. And also I found that in some context, hope can be almost not helpful in the sense that like if you're overly hopeful, you just sort of assume someone else is going to solve it and it sort of prevents you from taking action. But the type of hope that you're talking about and the type of hope that, that I love so much is the hope that drives action. It's like, because I can see what I'm hoping for because I want to help these young people in these communities like you do, or in our case patients with these diseases, like we try to help, that's going to drive action. And when, when there's this like hope and action circuit. I find that you can get even more hopeful and then do even more action and then be more hopeful and drive even more change.

[Selena de Sola]

100%. As you were saying, the hope in action, I'm like, it's cyclical, right? Yeah. Yeah. Because as you do it, you're like, okay, okay. And even if you have to take it like 12 steps back, you're like, okay, back to the grind. Yeah. And I definitely have to draw people around me a lot of times for that hope and the energy to do it.

[David Fagenbaum]

What's your philosophy, your leadership philosophy, like for how you lead your team? Teams and make change?

[Selena de Sola]

Oh my gosh. I mean, I feel like so much of leadership is about doing things together and knowing when to get out of the way. Right. And I think. And asking for help. I've always found it hard to ask for help generally. And I think almost 20 years into our organization, it's just really asking for help and being, you know, just being okay with stepping back on a lot of things. And I, and I, I think that the other thing that's been really important is to build a really diverse team and understand, you know, where what my weaknesses are, what, what are, you know, different people's strengths are and, and find people that bring different, different skill sets, different knowledge, different approaches, different attitudes to the work to keep it dynamic and more, I think, more productive.

[David Fagenbaum]

Love that.

[Selena de Sola]

How about you? What do you think? What's your leash? How big is your team?

[David Fagenbaum]

So we've got about 50 people that are part of every cure and then about 20 people that are part of my lab at Penn. And so for me, similar to what you mentioned, I think one part of having a really effective team is just assembling the right people to be a part of this really effective, assembling, mission driven team people where like, they are here to help patients. That's why they're here. They're not here for a paycheck. They're here to help patients. I think that's number one. So recruiting is so important. I think if you put a lot of time into finding the right people. And the second thing is really being able to set that vision of what we're working towards and making sure just to constantly remind everyone of what that vision is. You know, we recruited you to save and improve lives. You are the best person in the world to help us do that. You're the, the best person in the world to build our AI platform to help us save and improve lives. But it's always to save and improve lives. And I think visualizing, as we talked about earlier, is so important. That's like literally showing patients that are here because of a repurposed drug and also showing patients who are waiting for a drug. And I think that that sort of being able to really visualize, it's so powerful for me, and I think it's helpful for our team. And then I think the third thing is maybe obvious, but I just think that over communication is so important. I think that anytime you're facing big challenges, like you're facing and like we're facing, there's so many cases where you could get misaligned on one thing or another. But just keeping the conversation going, continuing to communicate, just being present with one another, working together is so important. And that's challenging for my group and I'm sure for yours as well, because we are located in a number of different locations. And so you aren't always able to, you know, bump into someone as, you know, over lunch. Right. You have to really be intentional about communication.

[Selena de Sola]

Yeah. And it is. I mean, we're working different countries, different time zones, and we have a really big team of people. It is really hard. Communication is hard. And I think you're right about maintaining that fluid. And I'd say not just with our teams. I also think leadership is about what interactions and partnerships we're developing with who right outside of the institution. And I think also maintaining the humility as an organization, especially when you're working with system, systems to know that you're, you know, you're not within that system, so you can't necessarily understand everything that they're going through. So I think we've learned as an organization and in our leadership, whoever it is in the organization, when we're working with people from other sectors, particularly from government sector, to know that. To maintain kind of that. That humility and curiosity about what it's. You know, maintain the humility and curiosity about what. That. What it. What it's like and what they need, what their priorities are and what they're interested in.

[David Fagenbaum]

Well, I love that you called out humility and curiosity, because I just think those are two ingredients that you need in every single team and every single problem that you're trying to solve. Because if it was easy to solve, then someone else would have done it and we wouldn't be working so hard. So we got to be humble because these are tough challenges. Well, this has been so awesome. I've so enjoyed spending this time with you.

[Selena de Sola]

Great. Congratulations.

[David Fagenbaum]

Oh, you as well.

[Elise Hu]

That was a conversation between Selena de Sola and David Fagenbaum for our original series ted intersections. Visit Ted.com to watch this conversation and others from the series. If you're curious about Ted's curation, find out [e-mail] curationguideline and that's it for today. TED Talks Daily is part of the TED Audio Collective. This talk was fact checked by the TED Research team and produced and edited by our team, Martha Estefanos, Oliver Friedman, Brian Greene, Lucy Little and Tansika Sangmarnival. This episode was mixed by Christopher Faizy Bogan. Additional support from Emma Tobner and Daniela Balarazo. I'm Elise Hu. I'll be back tomorrow with a fresh idea for your feed. Thanks for listening. This episode is brought to you by Progressive Insurance. Do you ever think about switching insurance companies to see if you could save some cash? Progressive makes it easy. Just drop in some details about yourself and see if you're eligible to save money when you bundle your home and auto policies. The process only takes minutes and it could mean hundreds more in your pocket. Visit progressive.com after this episode to see if you could save Progressive Casualty Insurance Company and affiliates. Potential savings will vary. Not available in all states.

[Selena de Sola]

Ready to order? Yes. We're earning unlimited 3% cash back on dining and entertainment with a Capital One Saver Card.

[Elise Hu]

So let's just get one of everything.

[Selena de Sola]

Everything.

[David Fagenbaum]

Fire everything. The Capital One Saver card is at table 27 and they're earning unlimited 3% cash back.

[Selena de Sola]

Yes, Chef. This is so nice.

[David Fagenbaum]

Had a feeling you'd want 3% cash back on dessert.

[Selena de Sola]

Ooh, tiramisu.

[David Fagenbaum]

Earn unlimited 3% cash back on dining and entertainment with the Capital One Saver Card. Capital One what's in your wallet?

[Selena de Sola]

Terms apply. See capitalone.com for details.

[David Fagenbaum]

In a world of seismic change, will your business shape the future or be shaped by it? How will we capture the imagination of tomorrow's consumers? Overcome operational constraints to focus on future.

[Selena de Sola]

Growth and unlock economic and social prosperity through Environmental responsibility? With EY's full spectrum of services across.

[David Fagenbaum]

Sectors, we're all in to shape the future with confidence.

[Selena de Sola]

Start your transformation [e-mail] transformation.